While I have always liked health-care giant Johnson & Johnson, it's hard to recommend taking a position at these levels. The stock is already up more than 22 percent on the year and trading at a price/earnings ratio …
Johnson & Johnson (NYSE:JNJ) Wednesday June 21, 2016 said that Louise Mehrotra, Vice President of …
This recent acquisition I decided to go with the very famous and beloved by dividend growth investors, Johnson & Johnson (JNJ). Very hard to resist such a premium company trading near 16 P/E. It has done great over the …
Johnson & Johnson (NYSE:JNJ) beat the analysts’ sales and earnings estimates as it reported results for the first quarter of its fiscal year 2015, on Tuesday. However, the announcement of the better-than-expected …
Barclays made the following changes in ratings on the following stocks on November 29: Barclays PLC has upgraded the stock of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) to Overweight from its previous rating of …
Johnson & Johnson (JNJ) : Stock Yards Bank Trust Co reduced its stake in Johnson & Johnson by 0.47% during the most recent quarter end. The investment management company now holds a total of 70,388 shares …
Simon provides outperforming buy and sell opinions on stocks, currencies, bonds, commodities, and real estate. His in-depth research covers most of the major financial markets in America. His research is based on the …
The analyst has a price target of $140 on Johnson & Johnson shares implying that the stock presents more …
Johnson & Johnson
Stating a potential upside of 0.06%, Vetr Inc. bumped up the target of Johnson & Johnson (NYSE:JNJ) to …
Johnson & Johnson (JNJ) and Procter & Gamble (PG) are huge consumer goods companies, with one or the other likely owned by most well-diversified dividend investors. With PG’s dividend yield of 3.5% slightly more …